查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197874

氧合器市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Oxygenators Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在 2022 年至 2027 年的預測期內，氧合器市場的複合年增長率為 5.4%。

為應對當前的 COVID-19 形勢，公司正在全球範圍內提高氧合器的產量，以支持採用 ECMO 程序治療 COVID-19 患者。 ICU 病房對氧氣呼吸器的需求顯著增加。 此外，市場參與者正在推出氧合器相關產品，因為這些設備代表了 COVID-19 患者外科手術和管理中重症監護的最重要方面。 COVID-19 還影響了 2020 年氧氣呼吸器產品的生產。 此外，由於 COVID-19 相關措施導致擇期手術的延誤對氧氣呼吸器等醫療設備產生了負面影響，尤其是在 2020 年上半年。

推動市場增長的主要因素是由於生活方式的改變導致各種冠心病和中風的全球流行、外科手術的增加、有利的報銷措施以及老年人口的快速增長。 例如，根據世界衛生組織的數據，2019 年約有 1790 萬人死於心血管疾病，佔全球所有死亡人數的 32%，直接導致冠狀動脈搭橋手術的需求增加以及對高效治療的需求。在整個預測期內，用於醫療器械的人工肺正在推動市場增長。

此外，心血管疾病的負擔在世界範圍內不斷增加，並且是導致死亡的主要原因。 根據世界衛生組織 (WHO) 提供的 2020 年統計數據，缺血性心髒病佔全球所有死亡人數的 16%。 據同一消息來源稱，2019 年估計有 890 萬人死於缺血性心髒病。 心血管疾病患病率上升正在推動心肺手術和冠狀動脈旁路移植術 (CABG)，這可能會增加對氧合器的需求。

然而，採用微創手術（例如經皮冠狀動脈介入治療）、與氧氣輸送系統相關的風險以及美國 FDA 對必須滿足性能標準的 II 類設備的嚴格規定阻礙了整個市場的增長。它作為因素

氧合器市場趨勢

膜氧合器領域有望佔據最大市場份額

與氣泡式氧合器相比，膜式氧合器可以抑制組織損傷和血栓形成。它被周期性採用，預計在預測期內將佔據最大的市場份額。 此外，它的快速部署、在相對較小的膜表面積上進行有效的氣體交換、改善血流、減少溶血和減少術後出血是推動這一領域增長的進一步因素。

按應用來看，呼吸領域預計在預測期內將佔據很大的市場份額。 這可能是由於慢性阻塞性肺病 (COPD) 和心肺疾病的患病率增加所致。

此外，2020 年 4 月，由印度科技部 (DST) 資助的印度公司 Genrich Membranes 開發了一種用於治療 COVID-19 患者的膜氧合器。底部。 因此，隨著早期未決操作的恢復，公司正在努力製造氧合器，從而增加了對該設備的需求。

北美有望在預測期內主導市場

美國是世界上受影響最嚴重的國家，因為非緊急手術已被擱置，減少了對這些設備的需求。 然而，隨著手術在適當的規定下恢復，人工肺的需求有望進一步增加，市場增長將逐漸增加。

在整個預測期內，預計北美將主導整個氧合器市場。 增長的一個主要驅動力是糖尿病和肥胖等慢性病以及急性呼吸窘迫綜合徵 (ARDS) 等急性呼吸系統疾病以及 CAD、缺血性中風和心房顫動等多種心血管疾病的增加。 ，需要進行心肺旁路手術，因此增加了對人造肺的需求。 例如，根據疾病控制和預防中心的數據，到 2021 年，心髒病將導緻美國四分之一的死亡。 冠心病是美國心血管疾病相關死亡的主要原因，導致 360,900 人死亡，其次是中風 (805,000)。 在此背景下，對有效劑量的更好治療的需求正在增加，推動了美國市場的發展。

此外，有利的報銷政策、食品藥品監督管理局 (FDA) 的批准、該地區醫療基礎設施的可用性等預計將在預測期內提振市場。

制氧機市場競爭分析

制氧器市場競爭激烈，由幾家主要參與者組成。 一些主要參與者正在推出採用先進技術的新產品以與現有產品競爭，而其他一些則正在收購或與市場上流行的其他公司合作。 目前主導市場的公司包括 Medtronic PLC、Terumo Medical Corporation、Getinge AB、EUROSETS SRL 和 Livanova PLC。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 全球心肺疾病患病率上升
    • 老齡化人口不斷增加，全球醫療保健支出不斷增加，可支配收入不斷增加
    • 技術先進產品的可用性和報銷政策
  • 市場製約因素
    • 介紹微創手術和與供氧系統相關的風險
    • 嚴格的 FDA 法規
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（按價值計算的市場規模：百萬美元）

  • 產品類型
    • 氣泡充氧器
    • 膜氧合器
  • 用法
    • 呼吸系統
    • 心
    • 體外心肺復蘇 (ECPR)
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Chalice Medical Ltd
    • EUROSETS SRL
    • Getinge AB
    • Livanova PLC
    • Medtronic PLC
    • Microport Scientific Corporation
    • Nipro Medical Corporation
    • Terumo Medical Corporation
    • Braile Biomedica
    • Xenios AG
    • MC3 Cardiopulmonary
    • Gen World Medical Devices
    • Senko Medical Instrument Mfg Co. Ltd（MERA）
    • Owgels Group

第7章 市場機會今後動向

簡介目錄
Product Code: 68208

The oxygenators market is expected to register a CAGR of 5.4% during the forecast period 2022-2027.

To cope with the current COVID-19 situation, companies are increasing the production of oxygenators globally to support the adoption of ECMO procedures for the treatment of COVID-19 patients. There has been a huge increase in the demand for oxygenators in ICU units. In addition, these devices have the most significant aspects of critical care in surgical procedures and the management of COVID-19 patients; therefore, market players are launching products associated with oxygenators. COVID-19 also impacted the production of oxygenator products in 2020. Furthermore, the delay of elective procedures due to COVID-19-related measures adversely affected medical devices such as oxygenators, especially in the first half of 2020.

The major factors driving the growth of the market are the global prevalence of various coronary heart diseases and strokes due to changing lifestyles, leading to a rise in surgical interventions, favorable reimbursement initiatives, and rapid growth of the geriatric population. For instance, according to the World Health Organization, nearly 17.9 million people died from cardiovascular diseases in 2019, representing 32% of all global deaths, which directly resulted in higher demand for coronary artery bypass procedures, leading to a rising focus on oxygenators for efficient treatments, fueling the growth of the market throughout the forecast period.

Moreover, there is a rising burden of cardiovascular diseases across the world, and they are the leading causes of death. As per the 2020 statistics provided by the World Health Organization (WHO), ischemic heart disease is responsible for 16% of the world's total deaths. As per the same source, an estimate of 8.9 million deaths were reported for ischemic heart disease in 2019. The rising prevalence of cardiovascular diseases is driving cardiopulmonary surgeries and coronary artery bypass grafting (CABG), which may increase the demand for oxygenators.

However, the adoption of minimally invasive procedures, like percutaneous coronary interventions, risks associated with oxygenation systems, and stringent US FDA regulations for Class II category devices, which should comply with the performance standards, are acting as barriers to the overall market growth.

Oxygenators Market Trends

The Membrane Oxygenators Segment is Expected to Hold the Largest Market Share

The membrane oxygenators segment is expected to witness the largest market share during the forecast period due to their rising adoption in CABG procedures and extracorporeal circulation for cardiopulmonary support in various surgical procedures, along with heart-lung machines, due to advantages such as reduction of the damage of tissues and thrombosis compared to bubble oxygenators. Also, their rapid deployability, effective gas exchange in a relatively small membrane surface area, enhanced blood flows, less hemolysis, and less post-operative bleeding further boost the growth of the segment.

Based on application, the respiratory segment is expected to hold a major market share during the forecast period. This can be attributed to the rise in the prevalence of chronic obstructive pulmonary disease (COPD) and cardiopulmonary diseases.

Moreover, in April 2020, an Indian firm, Genrich Membranes, which is being funded by the Department of Science and Technology (DST), India, developed membrane oxygenator equipment for the treatment of COVID-19 patients. Hence, companies are working on manufacturing oxygenators as the surgeries that were put on hold during the initial days are now resuming, and thus, the demand for these devices is rising.

North America is Expected to Dominate the Market Over the Forecast Period

The United States has been the most affected country across the world, as the non-emergent surgical procedures were put on hold, due to which the demand for these devices will decrease. However, the surgical procedures are resuming now with proper regulating guidelines, which will further increase the demand for these oxygenators, and the market growth will gradually rise.

North America is expected to dominate the overall oxygenators market throughout the forecast period. The major factors attributing to the growth are rise in the global prevalence of multiple cardiovascular indications like CAD, ischemic strokes, and atrial fibrillation, along with acute respiratory disorders such as acute respiratory distress syndrome (ARDS), due to a rise in chronic diseases, such as diabetes and obesity, necessitating the cardiopulmonary bypass procedures and thus, rise in demand for oxygenators. For instance, according to the Center for Disease Control and Prevention, 2021, heart disease accounts for one in four deaths in the United States. Coronary heart disease is the leading cause of deaths attributable to cardiovascular disease in the United States causing 360,900 deaths, followed by stroke (805,000). This scenario is leading to a higher demand for better treatment with efficient medication, which is driving the market in the United States.

Furthermore, favorable reimbursement policies, approvals by the Food and Drug Administration (FDA), and availability of healthcare infrastructure in the region are expected to fuel the market during the forecast period.

Oxygenators Market Competitor Analysis

The oxygenators market is moderately competitive and consists of several major players. Few of the key players are launching new products with advanced technologies to compete with the existing products, while others are acquiring and partnering with other companies trending in the market. Some of the companies currently dominating the market are Medtronic PLC, Terumo Medical Corporation, Getinge AB, EUROSETS SRL, and Livanova PLC.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Global Prevalence of Cardiopulmonary Disorders
    • 4.2.2 Increasing Geriatric Population, Rise in Global Healthcare Expenditure, and Growth in Disposable Income
    • 4.2.3 Availability of Technologically Advanced Products and Reimbursement Policies
  • 4.3 Market Restraints
    • 4.3.1 Adoption of Minimally Invasive Procedures and Risks Associated with Oxygenation Systems
    • 4.3.2 Stringent FDA Regulations
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 Product Type
    • 5.1.1 Bubble Oxygenator
    • 5.1.2 Membrane Oxygenator
  • 5.2 Application
    • 5.2.1 Respiratory
    • 5.2.2 Cardiac
    • 5.2.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Chalice Medical Ltd
    • 6.1.2 EUROSETS SRL
    • 6.1.3 Getinge AB
    • 6.1.4 Livanova PLC
    • 6.1.5 Medtronic PLC
    • 6.1.6 Microport Scientific Corporation
    • 6.1.7 Nipro Medical Corporation
    • 6.1.8 Terumo Medical Corporation
    • 6.1.9 Braile Biomedica
    • 6.1.10 Xenios AG
    • 6.1.11 MC3 Cardiopulmonary
    • 6.1.12 Gen World Medical Devices
    • 6.1.13 Senko Medical Instrument Mfg Co. Ltd (MERA)
    • 6.1.14 Owgels Group

7 MARKET OPPORTUNITIES AND FUTURE TRENDS